Evoke Pharma Q3 EPS $(0.45), Inline, Sales $4.284M Miss $4.326M Estimate

Evoke Pharma (NASDAQ:EVOK) reported quarterly losses of $(0.45) per share which met the analyst consensus estimate. This is a 52.13 percent increase over losses of $(0.94) per share from the same period last year. The company reported quarterly sales of $4.284 million which missed the analyst consensus estimate of $4.326 million by 0.97 percent. This is a 61.42 percent increase over sales of $2.654 million the same period last year.